James increased the price target for INmune Bio Inc. (NASDAQ: NASDAQ:INMB) shares to $23 from the previous $18, while maintaining an Outperform rating. According to InvestingPro data, the stock ...

Boca Raton, Florida Wednesday, February 12, 2025, 16:00 Hrs [IST] ...

BOCA RATON, FLORIDA - INmune Bio , Inc. (NASDAQ: NASDAQ:INMB), a clinical-stage biotechnology company with a market capitalization of $212.74 million, announced today its plans to submit regulatory ...

Agricultural genetics is the applied study of the effects of genetic variation and selection used to propagate valuable heritable trait combinations in crop plants and farm animals. The discipline ...

CLEVELAND, Feb. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in ...

Leber congenital amaurosis (LCA) and early-onset severe retinal dystrophy (EOSRD) are both genetically and phenotypically heterogeneous, and characterised clinically by severe congenital/early infancy ...

Scientists have discovered how to overcome the genetic defect that causes the most serious form of muscular dystrophy, it was revealed today. Although at an early stage, the research may lead to ...

Diabetes Test Results: Types of Tests and How to Read Them If you or someone in your family has diabetes, you might be wondering if it is genetic. There are different types of diabetes. For each type, ...

The cone rod dystrophy (CRD) market is growing at a rapid pace due to the progress of gene therapies and increased focus on rare genetic retinal disorders. The availability of better diagnostic ...

RDEB is a genetic skin disorder. It is the most severe subtype of dystrophic epidermolysis bullosa (DEB). RDEB produces generalized cutaneous and mucosal blistering. As I noted earlier ...